Insights from 2023 WCLC
Playback speed
10 seconds
WCLC 2023 Insights: "Results of the SQUINT Trial - Do MAPK1/MAPK3 Mutations Enhance IO Efficacy in Lung Squamous Cell Carcinoma?"
By
Insights from 2023 WCLC
FEATURING
Gabriele Minuti
By
Insights from 2023 WCLC
FEATURING
Gabriele Minuti
69 views
October 9, 2023
Comments 0
Login to view comments.
Click here to Login
Videos